UnicoCell's business is centered on regenerative medicine. We focus on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life.
UnicoCell's cell bank is the leading allogeneic cell bank of adipose stem cell source in Taiwan, built in accordance with ICH regulations (The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). Our Gold Award new stem cell investigational product ELIXCYTE® has been tested on clinical trials for knee osteoarthritis and chronic kidney disease. Stem cell derived technology is also used in the development of retinal degenerative diseases treatment and other regenerative medicine applications. We hope to contribute to society through stem cell technology research and development by continuing to improve quality and developing mass production technologies.
Company Details
- Employees
- 11
- Founded
- 2011
- Address
- 5f., No. 13-20, Sec. 6, Minquan E. Rd., Neihu Dist., Taipei City, Taipei City,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.unicocell.com/
- HQ
- Taipei city
向榮生技unicocell Biomed Questions
向榮生技Unicocell Biomed's website is https://www.unicocell.com/
向榮生技Unicocell Biomed's LinkedIn profile is https://tw.linkedin.com/company/%E5%90%91%E6%A6%AE%E7%94%9F%E6%8A%80
向榮生技Unicocell Biomed has
11 employees.
View email and phone details for 11
employees at 向榮生技Unicocell Biomed.
向榮生技Unicocell Biomed's industry is
Biotechnology Research
向榮生技Unicocell Biomed's top competitors are
Krisan Biotech Co., Ltd.,
Lumistar Biotechnology, Inc. 昱星生物科技,
King's Ground Biotech,
Febico遠東生技,
Academia Sinica, Taiwan,
Acro Biomedical Co., Ltd.,
Geneonline,
Steminent Biotherapeutics,
Amaran Biotech,
Tfbs Bioscience, Inc..
向榮生技Unicocell Biomed's categories are Biotechnology Research
向榮生技Unicocell Biomed's founding year is 2011
